Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives
eBook - ePub

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives

  1. 286 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives

About this book

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives provides high level knowledge on detailed mechanisms of actions and biological interactions of different immune drugs, with an aim of offering researchers and clinicians cutting-edge therapies to overcome drug resistance. The book explains the latest immunotherapies for different types of cancer, helping users carry out research projects or create alternatives for drug development in the pharmaceutical industry. Topics discussed include the relationship between immunotherapy and macrophages, immune checkpoints in different types of cancer, immune cocktails in solid tumors, and immune-phenotyping. Additionally, the book presents basic and clinical data on immunoresistance and glycosylation. This book is a valuable source for cancer researchers, medical doctors, clinicians and members of the biomedical field who must understand certain mechanisms to fight cancer that is resistant to immunotherapy. - Provides basic and clinical evidence based on molecular interactions and clinical studies to address the risks and benefits of cancer immunotherapy - Presents the results of new immunotherapy trials, discussing the state-of-the-art in different types of cancer - Discusses targeted therapies approved by the FDA, along with therapies with clinical potential used in basic studies

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives by Jorge Morales-Montor,Mariana Segovia-Mendoza,Jorge Morales Montor,Mariana Segovia in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.

Information

Table of contents

  1. Title of Book
  2. Cover image
  3. Front Matter
  4. Title page
  5. Table of Contents
  6. Copyright
  7. Cover Figure Insert
  8. Aims and Scope for Series Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
  9. About the Series Editor
  10. Aims and Scope of the Volume
  11. About the Volume Editors
  12. Preface
  13. Contributors
  14. Chapter 1 Cancer vs immune tolerance—The challenge of fighting ā€œselfĀ ā€
  15. Chapter 2 Immunoconjugates as immune canoes to kill breast cancer cells
  16. Chapter 3 New intratumoral immunotherapeutic approaches to inhibit the tumor growth and metastasis in breast cancer
  17. Chapter 4 The Fas/FasL pathway as a target for enhancing anticancer adoptive cell therapy
  18. Chapter 5 Harnessing metabolism for reinvigorating dysfunctional T cells in cancer
  19. Chapter 6 The IgM as a tool for recognition of early tumoral antigens
  20. Chapter 7 The inflammation during colorectal cancer: A friend or a foe?
  21. Chapter 8 Environmental pollution as a risk factor to develop colorectal cancer: The role of endocrine-disrupting chemicals in the inflammatory process as a risk factor to develop colorectal cancer
  22. Chapter 9 Targeting the STAT6 signaling pathway as a therapy against colon cancer
  23. Chapter 10 Macrophage migration inhibitory factor (MIF): Its role in the genesis and progression of colorectal cancer
  24. Chapter 11 Fcγ receptors—Master regulators of antibody therapy
  25. Chapter 12 Novel immunotherapy strategies involving matrix metalloproteinase (MMP) family
  26. Index